Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levosimendan for right heart function in acute decompensated heart failure
ChiCTR-IPR-16009974Phase 4Not yet recruiting
- Sponsor
- The Second Hospital of Hebei Medical University
- Start
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of levosimendan in heart failure (HF) (2 arms), sponsored by The Second Hospital of Hebei Medical University. Primary endpoints: BNP, cardiac troponin I and 6 more. Planned start Jan 2017; status: not yet recruiting.
02
Drugs
levosimendan
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on ChiCTR-IPR-16009974.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-16009974.